🇺🇸 Levo-Leucovorin in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Chills — 2 reports (18.18%)
  2. Aspartate Aminotransferase Increased — 1 report (9.09%)
  3. Band Neutrophil Count Increased — 1 report (9.09%)
  4. Electrolyte Imbalance — 1 report (9.09%)
  5. Heart Rate Increased — 1 report (9.09%)
  6. Leukopenia — 1 report (9.09%)
  7. Petechiae — 1 report (9.09%)
  8. Pyrexia — 1 report (9.09%)
  9. Thrombocytopenia — 1 report (9.09%)
  10. Tremor — 1 report (9.09%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Levo-Leucovorin approved in United States?

Levo-Leucovorin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Levo-Leucovorin in United States?

Fujian Cancer Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.